Abstract: Sertraline hydrochloride polymorphic form II is conveniently prepared by adding hydrogen chloride to solution of sertraline free amine in a ketone. In preferred processes, the solution of sertraline free amine seeded with some crystals of polymorphic form II and/or the solution is heated before addition of the hydrogen chloride.

Abstract: The invention relates to new reactive diluents of the formulae (Ia, Ib, Ic, Id, Ie) and to an alkyd coating composition comprising them. In a preferred embodiment R1 and R2 are hydrogen; R3 is (meth)acryloyloxy-methyl or phenyl para substituted by vinyl, R4 is phenyl or phenyl para substituted by vinyl or (meth)acryloyloxy; or a substituted phenyl residue of the formula —C6H4CH2—W, wherein W is (meth)acryloyloxy, or an aliphatic residue of the formula —CH2—Y-A, wherein Y is a bond, O—C1-C12alkylene, wherein the alkylene linker is linear or branched and may be interrupted once or more than once by oxygen, A is hydroxy, C1-C6alkoxy, acetoxy, (meth)acryloyloxy, or a phthalate- or maleate-residue; R5 is hydrogen; n is 1; X is —(CH2)—. The invention further relates to a solvent-based or water-based alkyd coating composition comprising 0.3 to 10 wt. % of a mono-, bis- or trisacylphosphinoxide photoinitiator, especially Irgacure 819.

Abstract: An amine ether of formula A wherein a is 1 or 2; and when a is 1, E is E?; when a is 2, E is L; E? is C1-C36 alkyl; C3-C18 alkenyl; C2-C18 alkinyl; C5-C18 cydoalkyl; C5-C18 cycloalkenyl; a radical of a saturated or unsaturated aliphatic bicyclic or tricyclic hydrocarbon of 7 to 12 carbon atoms; C2-C7alkyl or C3-C7alkenyl substituted by halogen; C7-C15 aralkyl or C7-C15 aralkyl substituted by C1-C4 alkyl or phenyl; or E? is a radical of formula (VII) as explained in claim 1; T? is tertiary C4-C18alkyl or phenyl, each of which are unsubstituted or substituted by halogen, OH, COOR21 or C(O)—R22; or T? is C5-C12cycloalkyl; C5-C12 cycloalkyl which is interrupted by at least one O or —NR18—; a polycyclic alkyl radical having 7-18 carbon atoms, or the same radical which is interrupted by at least one O or —NR18—; or T? is —C(G1)(G2)—T?; or C1-C18alkyl or C5-C12cycloalkyl substituted by T? is hydrogen, halogen, NO2, cyano, or is a monovalent organic radical comprising 1-50 carbon atoms; or T? and T? toge

Abstract: The invention relates to novel synthesis methods for the preparation of the intermediates, which are suitable for the preparation of statin derivatives, especially to novel synthesis methods of the intermediate of formula VI wherein Ra and Rc are each independently of the other hydrogen or a hydroxy-protecting group or together are a bridging hydroxy-protecting group, and Rb is a carboxy-protecting group, which methods are carried out by conversion of the intermediate of formula XIX wherein Ra and Rc are each independently of the other hydrogen or a hydroxy-protecting group, and Rb is a carboxy-protective group.